Methotrexate-loaded magnetosome drug carrier and preparation method thereof
A technology of methotrexate and magnetosomes, which is applied in the direction of drug combinations, pharmaceutical formulas, medical preparations of non-active ingredients, etc., can solve the problems of toxic side effects, poor water solubility, etc., and achieve high drug loading and long release cycle , anti-inflammatory and therapeutic effects on soft tissue injuries
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0024] The present invention also relates to a preparation method of a magnetosome drug carrier loaded with methotrexate, comprising the following steps:
[0025] Step 10, dispersing the purified and freeze-dried magnetosome particles in a solvent, and then adding methotrexate solution;
[0026] Step 20, ultrasonically dispersing the mixed liquid in step 10, and fully mixing;
[0027] Step 30, add the genipin solution, and continue to disperse evenly by ultrasonic;
[0028] Step 40, putting the mixed solution in step 30 into a shaker for cross-linking, and obtaining the magnetosome drug carrier loaded with methotrexate after the cross-linking is saturated.
[0029] The magnetosomes are extracted from magnetotactic bacteria.
[0030] Preferably, the solvent in step 10 is PBS buffer or physiological saline.
[0031] Preferably, the ultrasonic dispersion in step 30 is intermittent ultrasonic dispersion.
[0032] Preferably, the step 40 specifically includes: putting the mixed...
Embodiment 1
[0035] Disperse the purified and freeze-dried magnetosome particles in a PBS solution with a pH of 7.4 to obtain a magnetosome solution with a concentration of 0.1 mg / mL; then add an equal amount of methotrexate solution and ultrasonically disperse (50W, 5min). After fully mixing, add 10mg / mL genipin solution to make the concentration of genipin in the mixture 1mg / mL, continue intermittent ultrasonic dispersion (50W, 1min each time, 5min interval), repeat 10 times, and then put the mixture Into a 37°C, 60rpm shaker for cross-linking for 24h.
[0036] Finally, the drug loading capacity of the magnetosome drug carrier loaded with methotrexate was 48.6%, the encapsulation efficiency was 94.4%, the release amount in 0.5 hours was 4.8%, there was no burst release effect, and the cumulative release was two months The rate is 82.4%.
Embodiment 2
[0038] This embodiment is basically the same as Embodiment 1, except that the concentration of genipin in the mixed solution is 0.5 mg / mL.
[0039] Finally, the drug loading capacity of the magnetosome drug carrier loaded with methotrexate was 48.0%, the encapsulation efficiency was 86.6%, the release amount in 0.5 hours was 5.4%, there was no burst release effect, and the cumulative release was two months The rate is 82.1%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com